Darwin Global Management, Ltd.
Q2 2023 13F-HR Holdings
Net value change ($000)
+246,078
(67.3%)
New positions
0
Sold out positions
1
Turnover %
0.2%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q1 2023
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| Ambrx Biopharma Cayman, Inc. | 173,858 | 172.4% |
| TGTX | 73,289 | 46.6% |
| ARGX | 271 | 0.3% |
Top Reduces (Value $000, Stocks/ETFs)
| KROS | -1,340 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|